GlassScriptPhysician profile
Kyle Colquhoun
NPI 1841674454
$2,494.26
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.48 · 2022: $143 · 2023: $1,972 · 2024: $140 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,366 · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,365.80 |
| Food and Beverage | $941.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $1,712.34 | 2023 | Orbera Intragastric Balloon System, Overstitch Endoscopic Suturing System |
| Astrazeneca Pharmaceuticals LP | $135.00 | 2023 | Imfinzi |
| Boston Scientific Corporation | $129.33 | 2021-2023 | Apollo Esg System |
| Gilead Sciences, INC. | $124.77 | 2024 | Epclusa |
| Olympus America INC. | $121.64 | 2025 | Single Use Repositionable Clip |
| Qol Medical, LLC | $90.09 | 2022-2023 | Sucraid |
| Novo Nordisk INC | $73.85 | 2025 | |
| Alexion Pharmaceuticals, INC. | $41.71 | 2022 | |
| Abbvie INC. | $29.06 | 2022 | |
| Lifenet Health | $20.86 | 2023 | |
| Phathom Pharmaceuticals, INC. | $15.61 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Colquhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.